Macrophage-Based Therapies for Atherosclerosis Management
Atherosclerosis (AS), a typical chronic inflammatory vascular disease, is the main pathological basis of ischemic cardio/cerebrovascular disease (CVD). Long-term administration was characterized with low efficacy and serious side effects, while the macrophages with attractive intrinsic homing target...
Saved in:
Main Authors: | Renyi Peng, Hao Ji, Libo Jin, Sue Lin, Yijiang Huang, Ke Xu, Qinsi Yang, Da Sun, Wei Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2020/8131754 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metabolic and epigenetic regulation of macrophage polarization in atherosclerosis: Molecular mechanisms and targeted therapies
by: Pinglian Yang, et al.
Published: (2025-02-01) -
Diverse Roles of Macrophages in Atherosclerosis: From Inflammatory Biology to Biomarker Discovery
by: Ting Gui, et al.
Published: (2012-01-01) -
Single-cell analysis identified key macrophage subpopulations associated with atherosclerosis
by: Zhao Zhenzhen, et al.
Published: (2024-12-01) -
Dual-mode-driven nanomotors targeting inflammatory macrophages for the MRI and synergistic treatment of atherosclerosis
by: Min Wei, et al.
Published: (2025-01-01) -
Bone marrow mesenchymal stem cell-derived extracellular vesicles alleviate diabetes-exacerbated atherosclerosis via AMPK/mTOR pathway-mediated autophagy-related macrophage polarization
by: Libo Liu, et al.
Published: (2025-01-01)